OpenExamsFREE PRACTICE — ANY EXAM

Maryland Pharmacist — Requirements & Free Practice

US-MD · License preparation

550 free questions · Answer explanations · No signup required

Choose what to practice

Start with an exam below. Your examination requirements depend on your application pathway. View licensing requirements

Combined practice

Choose an exam or combined practice to begin.

Licenses, application pathways and examination requirements

Each license and applicant pathway has its own requirements and exemptions. Choosing practice questions does not determine your eligibility.

Pharmacist License

Maryland license to practice pharmacy issued by the State Board of Pharmacy under Health Occupations Article, Title 12.

Licensing authority: Maryland State Board of Pharmacy · Application information

Licensure by examination: graduate of a foreign school or college of pharmacy

All of the following:

Exam IIChoice
Exam II is satisfied either by the Maryland MPJE or by the UMPJE together with the Maryland Pharmacy Law webinar and post-webinar test (COMAR 10.34.02.02B(3)(b)). NABP lists the Maryland MPJE retirement date as May 31, 2027.
Exam IIEligibility
Beginning May 1, 2026, the Board may approve an applicant to take Exam II on proof of graduation or of completion of the didactic portion of the core curriculum of a Board-approved or ACPE-accredited school (COMAR 10.34.02.03A(2)).
Foreign Graduate Waiver
The Board may waive the graduation requirement of §12-302(d)(1) for a graduate of a foreign school or college of pharmacy who passes an examination approved by the Board in addition to the examinations otherwise given by the Board (Health Occupations Article, §12-302(f)(2)).
Fpgec Certification
The applicant must be Foreign Pharmacy Graduate Examination Committee (FPGEC) certified with NABP and provide a copy of the FPGEC Certificate; a license cannot be issued until this requirement is met (Board initial application revised 06/09/2025; Board FAQ). Maryland official sources name the FPGEC certificate, not a specific examination.
Good Moral Character
The applicant must be of good moral character (Health Occupations Article, §12-302(b)).
Internship
1,560 hours of full-time training as a registered pharmacy intern under the direct supervision of Board-approved licensed pharmacists (COMAR 10.34.02.04B(1), 10.34.02.05); a Maryland intern license is required first (Board FAQ).
Lower Ranked Application Text
The Board initial application revised 06/09/2025 states: "You are required to take the North American Pharmacist Licensure Examination (NAPLEX), and the Multistate Pharmacy Jurisprudence Examination (MPJE)." COMAR 10.34.02.02 (amended effective March 2, 2026) also admits the UMPJE with the Maryland Pharmacy Law webinar and post-webinar test for Exam II.
Minimum Age
The applicant must be at least 18 years old (Health Occupations Article, §12-302(c)).
Naplex Score Transfer
A NAPLEX score obtained for another state may be transferred to Maryland through NABP (Board FAQ).
Oral English Competency
The applicant must pass Exam III, a Board-approved standardized test of oral English competency or the Board prescreening test of oral English competency, unless deemed proficient as a graduate of a recognized English-speaking professional school accredited by ACPE (Health Occupations Article, §12-302(g); COMAR 10.34.02.02B(3)(c) and 10.34.02.03D). This language test is a condition, not an examination leaf.
Score Validity
A passing score on Exam I or Exam II need not be retaken unless it was received more than 2 years before the candidate completed all other examination requirements (COMAR 10.34.02.03C(3)); the Board application and FAQ state that scores are good for one year from the date of examination.
Licensure by examination: graduate of a Board approved or ACPE accredited school or college of pharmacy

All of the following:

Education
Graduate of a school or college of pharmacy approved by the Board or accredited by the American Council on Pharmaceutical Education (Health Occupations Article, §12-302(d)(1); COMAR 10.34.02.03B(2)).
Exam IIChoice
Exam II is satisfied either by the Maryland MPJE or by the UMPJE together with the Maryland Pharmacy Law webinar and post-webinar test (COMAR 10.34.02.02B(3)(b)). NABP lists the Maryland MPJE retirement date as May 31, 2027.
Exam IIEligibility
Beginning May 1, 2026, the Board may approve an applicant to take Exam II on proof of graduation or of completion of the didactic portion of the core curriculum of a Board-approved or ACPE-accredited school (COMAR 10.34.02.03A(2)).
Good Moral Character
The applicant must be of good moral character (Health Occupations Article, §12-302(b)).
Lower Ranked Application Text
The Board initial application revised 06/09/2025 states: "You are required to take the North American Pharmacist Licensure Examination (NAPLEX), and the Multistate Pharmacy Jurisprudence Examination (MPJE)." COMAR 10.34.02.02 (amended effective March 2, 2026) also admits the UMPJE with the Maryland Pharmacy Law webinar and post-webinar test for Exam II.
Minimum Age
The applicant must be at least 18 years old (Health Occupations Article, §12-302(c)).
Naplex Score Transfer
A NAPLEX score obtained for another state may be transferred to Maryland through NABP (Board FAQ).
Oral English Competency
The applicant must pass Exam III, a Board-approved standardized test of oral English competency or the Board prescreening test of oral English competency, unless deemed proficient as a graduate of a recognized English-speaking professional school accredited by ACPE (Health Occupations Article, §12-302(g); COMAR 10.34.02.02B(3)(c) and 10.34.02.03D). This language test is a condition, not an examination leaf.
Professional Experience
Completion of the Board-required professional experience program: 1,000 hours of a school-supervised professional experience program conducted by an ACPE-accredited school of pharmacy (COMAR 10.34.02.04A), or otherwise 1,560 hours as a registered pharmacy intern (COMAR 10.34.02.04B).
Score Validity
A passing score on Exam I or Exam II need not be retaken unless it was received more than 2 years before the candidate completed all other examination requirements (COMAR 10.34.02.03C(3)); the Board application and FAQ state that scores are good for one year from the date of examination.
Licensure by reciprocity: pharmacist licensed in another state

At least one of the following alternatives:

  • Maryland Multistate Pharmacy Jurisprudence Examination (practice unavailable)

  • All of the following:

    • Uniform MPJE
    • Maryland Pharmacy Law Webinar and Post-Webinar Exam (practice unavailable)
Experience
Evidence of at least 520 hours of pharmacy experience after graduation from a Board-approved or ACPE-accredited school or college of pharmacy (COMAR 10.34.15.01A(3)).
Foreign Graduates
Foreign graduates must also provide the FPGEC certificate (Board reciprocity application revised 06/09/2025; Board FAQ).
Jurisprudence Source Disagreement
COMAR 10.34.15.01A(4) states "Pass the MPJE; and", while COMAR 10.34.02, which applies to "Applicants for licensure as a pharmacist", lets Exam II be satisfied by the UMPJE with the Maryland Pharmacy Law webinar and post-webinar test; the Board home page states that from June 1, 2026 pharmacist licensure applicants may choose the UMPJE or the state MPJE, and NABP lists Maryland as requiring the UMPJE for licensure transfer. The Board has posted a proposed amendment of COMAR 10.34.15.01A(4) reading "(a) Pass the MPJE; or (b) Pass the UMPJE and Maryland law webinar". Both alternatives are mounted; the applicant should confirm with the Board which one it will accept.
Nabp License Transfer
NABP License Transfer Application and Maryland Board reciprocity application (Board FAQ).
Oral English Competency
Pass the exam of oral English competency described in COMAR 10.34.02 unless the candidate documents an equivalent oral English competency exam passed in another state (COMAR 10.34.15.01A(5), .01B). This language test is a condition.
Other State License
The applicant holds a license to practice pharmacy in another state (COMAR 10.34.15.01; Board FAQ).
Prior Examination
Under Health Occupations Article, §12-305(b)(3)(ii), the Board may waive examination requirements only for an applicant who became licensed in the other state after passing an examination approved by the Board; this prior score is evidence, not an examination taken for this route.
Reinstatement of a pharmacist license expired 2 years or more but less than 10 years
Maryland Multistate Pharmacy Jurisprudence Examination (practice unavailable)
General Requirements
Reinstatement application with continuing education, evidence of good standing in any other state of licensure, and the reinstatement fee (COMAR 10.34.13.03A).
Jurisprudence Exam
COMAR 10.34.13 requires the MPJE; the Board home page states that from June 1, 2026 pharmacist licensure applicants may choose the UMPJE with the Maryland-specific module instead of the state MPJE, which COMAR 10.34.13 does not provide for reinstatement.
Licensed Elsewhere2to5Years
Pharmacist licensed and practicing in another state, Maryland license expired 2 to less than 5 years: also documents pharmacy experience during the preceding 2 years (COMAR 10.34.13.03B(4)).
Not Practicing2to5Years
Pharmacist not practicing, Maryland license expired more than 2 but less than 5 years (COMAR 10.34.13.03B(5)).
Not Practicing5to10Years
Pharmacist not practicing in another state, Maryland license expired more than 5 but less than 10 years: also 1,000 hours of service in a permitted pharmacy under the supervision of a licensed pharmacist (COMAR 10.34.13.03B(6)).
Waiver
The Board may waive any reinstatement requirement (COMAR 10.34.13.04).
Reinstatement of a pharmacist license expired 10 years or more (pharmacist not actively practicing)

All of the following:

General Requirements
Evidence of good standing in any other state of licensure and the reinstatement fee (COMAR 10.34.13.03B(7)(a)).
Jurisprudence Exam
COMAR 10.34.13 requires the MPJE; the Board home page states that from June 1, 2026 pharmacist licensure applicants may choose the UMPJE with the Maryland-specific module instead of the state MPJE, which COMAR 10.34.13 does not provide for reinstatement.
Service
1,000 hours of service in a permitted pharmacy under the supervision of a licensed pharmacist (COMAR 10.34.13.03B(7)(c)).
Waiver
The Board may waive any reinstatement requirement (COMAR 10.34.13.04).
Reinstatement of a pharmacist license expired less than 2 years, or of a pharmacist who kept practicing in Maryland after expiration
No examination is required for this applicant pathway.
Eligibility
Maryland license expired less than 2 years before applying (COMAR 10.34.13.03B(2)-(3)); a pharmacist who kept practicing in Maryland after expiration may be reinstated on the same requirements but may be charged with unlicensed practice (COMAR 10.34.13.03B(1)).
General Requirements
Reinstatement application with the continuing education required by COMAR 10.34.18, evidence of good standing in any other state of licensure, and the reinstatement fee (COMAR 10.34.13.03A).

Official no-examination sources

Effective from 2026-08-31.

Renewal of an unexpired pharmacist license
No examination is required for this applicant pathway.
First Renewal
A pharmacist licensed within 1 year of completing pharmaceutical education may renew once without continuing education (Health Occupations Article, §12-309(c)).
Renewal
Before expiration: renewal application on the Board form, renewal fee, and evidence of 30 hours of approved continuing pharmaceutical education within the preceding 2 years (Health Occupations Article, §§12-308(c), 12-309(a)); the Board FAQ adds that 2 CE hours must be live and 1 must cover medication errors.

Official no-examination sources

Effective from 2026-08-31.

Maryland Multistate Pharmacy Jurisprudence Examination

Provider
National Association of Boards of Pharmacy (NABP)
Passing score
75 (COMAR 10.34.02.03C(2)(a))
Examination outline
  • Licensure/Personnel (22%)
    • 1.1 – Responsibilities of the pharmacist and non-pharmacist personnel
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for pharmacists-in-charge (or equivalent) and pharmacists
    • Qualifications, scope of duties, limitations, and restrictions of duties, or conditions to practice for non-pharmacist personnel
    • 1.2 – Licensures, registrations, and certifications for pharmacists or non-pharmacist personnel
    • Qualifications, examinations, internships, maintaining pharmacist competency, and renewals of licensures, registrations, or certifications
    • Classifications and processes of disciplinary actions
    • Reporting to and participating in programs addressing the inability to practice with reasonable skill and safety
  • Pharmacist Practice (33%)
    • 2.1 – Requirements for issuing prescriptions/drug orders
    • Requirements for drug uses, limitations, or restrictions
    • Scope of authority, scope of practice, limitations or restrictions of practice, and valid registration of practitioners who are authorized to prescribe, dispense, or administer drugs
    • Requirements for issuing non-controlled prescriptions/drug orders
    • Requirements for issuing controlled prescriptions/drug orders
    • Authority limitations of practitioners’ ability to authorize refills
    • 2.2 – Conditions under which the pharmacist or non-pharmacist personnel participates in the administration of drugs in the management of patients’ therapy
    • 2.3 – Requirements regarding counseling
    • Counseling or offering to counsel
    • Documenting counseling or documenting offering to counsel
    • 2.4 – Returning or reusing drugs
    • 2.5 – Regulations and agencies regarding pharmacy practice
    • Requirements for promoting quality and safety of public health
    • Protecting patient and health record confidentiality
  • Dispensing Requirements (24%)
    • 3.1 – Responsibilities for determining whether prescriptions/drug orders are issued for a legitimate medical purpose, and within all applicable restrictions
    • 3.2 – Transferring prescription/drug order information between pharmacies by authorized personnel
    • 3.3 – Prospective drug utilization reviews
    • Requirements for reporting to PMP and accessing PMP data
    • 3.4 – Exceptions to dispensing or refilling prescriptions/drug orders
    • 3.5 – Labeling of dispensed drugs
    • 3.6 – Packaging of dispensed drugs
    • 3.7 – Drug product conditions prohibiting dispensing
    • 3.8 – Requirements for the distribution and/or dispensing of non-prescription pharmaceutical products, including controlled substances and hazardous drugs
    • Dispensing or administration
    • Labeling of non-prescription drugs and devices
    • Packaging and repackaging of non-prescription drugs and behind-the-counter products
    • Dispensing-restricted, non-prescription drugs
  • Pharmacy Operations (21%)
    • 4.1 – Ordering, acquisition, and distribution of drugs, including maintenance and content of such records
    • Ordering and acquisition, including the maintenance and content of such records
    • Distribution, including the maintenance and content of such records
    • 4.2 – Recordkeeping in compliance with legal requirements, including content, inventory, maintenance, storage, handling, and reporting
    • Non-dispensing requirements for operations of pharmacies or practice settings
    • Possession, storage, and handling of non-hazardous drugs
    • Training, possession, handling, storage, and disposal of hazardous drugs
    • Allowing non-pharmacist personnel access to drugs
    • Requirements for conducting controlled substance inventories
    • 4.3 – Delivery of drugs
    • 4.4 – Conditions for permitted or mandated product selection
    • 4.5 – Compounding sterile, nonsterile, hazardous, and non-hazardous preparations
    • 4.6 – Centralized prescription processing or central-fill pharmacy dispensing
    • 4.7 – Requirements for the registration, licensure, certification, or permitting of a practice setting or business entity
    • Requirements for registration, license, certification, or permitting of a practice setting
    • Requirements for the renewal or reinstatement of a license, registration, certificate, or permit of a practice setting
    • Requirements for an inspection of a licensed, registered, certified, or permitted practice setting
    • Classifications and processes of disciplinary actions that may be taken against a registered, licensed, certified, or permitted practice setting
Examination sources

Maryland Pharmacy Law Webinar and Post-Webinar Exam

Provider
University of Maryland School of Pharmacy, for the Maryland Board of Pharmacy
Format
Approximately 2 1/2 hours of video presentations followed by an online assessment
Exam questions
20
Passing score
85
Exam fee
No fee
Practice scope

Inferred from the examination name; the authority has not published an examination outline.

  • Health Occupations Article, Title 12 — Maryland Pharmacy Act
  • COMAR 10.34.01 Disciplinary Proceedings
  • COMAR 10.34.02 Examination for Licensure and Professional Experience Programs
  • COMAR 10.34.03 Institutional Pharmacy
  • COMAR 10.34.04 Transfer and Outsourcing of Prescriptions and Prescription Orders
  • COMAR 10.34.05 Pharmacy Security
  • COMAR 10.34.06 Reporting Pharmacist's, Pharmacy Intern's, and Pharmacy Technician's Mailing Address and Location of Employment
  • COMAR 10.34.07 Pharmacy Equipment
  • COMAR 10.34.08 Information Required on Prescriptions or Patient Drug Profiles
  • COMAR 10.34.10 Pharmacist, Pharmacy Intern, and Pharmacy Technician Code of Conduct
  • COMAR 10.34.11 Disciplinary Sanctions, Monetary Penalties, and Civil Fines
  • COMAR 10.34.12 Removal of Expired Medications
  • COMAR 10.34.13 Reinstatement of Expired Licenses for Pharmacists
  • COMAR 10.34.14 Opening and Closing of Pharmacies
  • COMAR 10.34.15 Licensure by Reciprocity
  • COMAR 10.34.16 Portable Drug Kits for Licensed Home Health Agencies, Hospices, and Home Infusion Providers Licensed as Residential Services Agencies
  • COMAR 10.34.17 Waiver of Full Service Requirements for Recognized Pharmaceutical Specialties
  • COMAR 10.34.18 Continuing Education for Pharmacists
  • COMAR 10.34.19 Sterile Pharmaceutical Compounding
  • COMAR 10.34.20 Format of Prescription Transmission
  • COMAR 10.34.21 Standard of Practice for Unlicensed Personnel
  • COMAR 10.34.22 Licensing of Wholesale Prescription Drug or Device Distributors
  • COMAR 10.34.23 Pharmaceutical Services to Patients in Comprehensive Care Facilities
  • COMAR 10.34.24 Record of Drug Inventory Acquisition
  • COMAR 10.34.25 Delivery of Prescriptions
  • COMAR 10.34.26 Patient Safety Improvement
  • COMAR 10.34.28 Automated Medication Systems
  • COMAR 10.34.29 Drug Therapy Management
  • COMAR 10.34.30 Change to Permit — Pharmacy or Wholesale Distribution Permit Holder
  • COMAR 10.34.31 Dispensing or Distributing at a Setting That Does Not Possess a Pharmacy Permit
  • COMAR 10.34.32 Pharmacist Administration of Vaccinations
  • COMAR 10.34.33 Prescription Drug Repository Program
  • COMAR 10.34.34 Pharmacy Technicians
  • COMAR 10.34.35 Infusion Pharmacy Services in an Alternate Site Care Environment
  • COMAR 10.34.36 Pharmaceutical Services to Residents in Assisted Living Programs and Group Homes
  • COMAR 10.34.37 Pharmacy Permit Holder Requirements — Wholesale Distribution and Nonresident Pharmacy Operations
  • COMAR 10.34.38 Pharmacy Interns
  • COMAR 10.34.39 Pharmacist Administration of Self-Administered Drugs
  • COMAR 10.34.40 Pharmacists Prescribing Contraceptives
  • COMAR 10.34.41 Administration of a Maintenance Injectable Medication
  • COMAR 10.34.42 Pharmacist Prescribing of a Nicotine Replacement Therapy Medication
Examination sources

North American Pharmacist Licensure Examination

Provider
National Association of Boards of Pharmacy
Format
Computerized fixed form
Exam questions
225 questions
Time limit
6 hours
Passing score
Pass or Fail
Examination outline
  • Foundational Knowledge for Pharmacy Practice (25%)
    • Pharmaceutical science principles and concepts
    • Pharmaceutical science principles and concepts: Pharmacology
    • Pharmaceutical science principles and concepts: Pharmacokinetics, pharmacodynamics, or pharmacogenomics
    • Pharmaceutical science principles and concepts: Pharmaceutics
    • Pharmaceutical compounding
    • Pharmaceutical compounding: Nonsterile preparations
    • Pharmaceutical compounding: Sterile preparations
    • Pharmaceutical calculations
    • Pharmaceutical calculations: Patient parameters or laboratory measures
    • Pharmaceutical calculations: Quantities of drugs to be dispensed or administered
    • Pharmaceutical calculations: Rates of administration
    • Pharmaceutical calculations: Dose conversions
    • Pharmaceutical calculations: Drug concentrations, ratio strengths, osmolarity, or osmolality
    • Pharmaceutical calculations: Quantities of drugs or ingredients to be compounded
    • Pharmaceutical calculations: Nutritional needs and the content of nutrient sources
    • Pharmaceutical calculations: Biostatistical, epidemiological, or pharmacoeconomic measures
    • Pharmaceutical calculations: Pharmacokinetic parameters
    • Drug development processes (eg, clinical trial phases, emergency use authorizations)
    • Research design principles and biostatistics (eg, blinding, randomization, biases, statistical tests and outcomes, ethics)
    • Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (25%)
    • Prescriptions and medication order interpretation
    • Prescriptions and medication order interpretation: Drug names and therapeutic classes
    • Prescriptions and medication order interpretation: Indications, usage, and dosing regimens
    • Prescriptions and medication order interpretation: Available dosage forms
    • Prescriptions and medication order interpretation: Prescription regulations (eg, boxed warnings, risk evaluation and mitigation strategies)
    • Prescriptions and medication order interpretation: Safety and effectiveness (eg, laboratory parameters, vital signs)
    • Therapeutic substitutions (eg, formulary restrictions, therapeutic alternatives, shortages, biosimilars)
    • Immunization services and documentation
    • Immunization services and documentation: Indications and scheduling
    • Immunization services and documentation: Contraindications and precautions
    • Immunization services and documentation: Storage and handling
    • Immunization services and documentation: Administration (eg, techniques, preparation, routes)
    • Immunization services and documentation: Adverse reactions
    • Medication handling, storage, stability, and disposal (eg, hazardous and nonhazardous drugs, controlled substances, parenteral medications, sharps handling, temperature control)
  • Person-Centered Assessment and Treatment Planning (40%)
    • Medication history, allergy history, and reconciliation
    • Health histories, screenings, and assessments
    • Patient health conditions, including special populations and medication-related factors
    • Patient health conditions, including special populations and medication-related factors: Signs, symptoms, and findings of medical conditions, etiology of diseases, or pathophysiology
    • Patient health conditions, including special populations and medication-related factors: Appropriateness of therapy (eg, medications, immunizations, non-drug therapy, dosing, contraindications, warnings, evidence-based decision making)
    • Patient health conditions, including special populations and medication-related factors: Interactions (eg, drug-drug, drug-condition, drug-food, drug-allergy, drug-laboratory)
    • Patient health conditions, including special populations and medication-related factors: Errors and omissions (eg, dosing, duplication, additional therapy needed, unnecessary therapy)
    • Patient health conditions, including special populations and medication-related factors: Adverse drug reactions
    • Patient health conditions, including special populations and medication-related factors: Toxicologic exposures and overdoses
    • Patient health conditions, including special populations and medication-related factors: Adherence
    • Therapeutic monitoring, plan development, evaluation, and modifications
    • Therapeutic monitoring, plan development, evaluation, and modifications: Therapeutic goals, clinical endpoints, and follow-up
    • Therapeutic monitoring, plan development, evaluation, and modifications: Safety
    • Therapeutic monitoring, plan development, evaluation, and modifications: Effectiveness
    • Patient education
    • Patient education: Lifestyle modifications and health maintenance
    • Patient education: Medication use, storage, and disposal
    • Patient education: Disease state management
    • Over-the-counter medications and dietary supplements
    • Devices to administer medications and self-monitoring tests
  • Professional Practice (5%)
    • Adverse drug event reporting and medication error reporting (eg, MedWatch, VAERS)
    • Public health initiatives and risk-prevention programs (eg, tobacco and nicotine cessation, antimicrobial stewardship, health screenings, opioid stewardship)
    • Social determinants and drivers of health
    • Ethical considerations (eg, informed consent, ethical principles, professional conduct and responsibility, patient confidentiality)
  • Pharmacy Management and Leadership (5%)
    • Pharmacy operations (eg, operational planning, risk management, regulations and regulatory bodies, technology applications and informatics, error-prevention strategies, medication safety)
    • Inventory and supply management (eg, drug recalls, drug shortages)
    • Quality improvement activities (eg, medication use evaluation, root-cause analysis, continuous quality improvement)
    • Mentorship and preceptorship (eg, providing and receiving feedback, delegation of work activities, preceptor roles)
Examination sources

Uniform MPJE

Provider
National Association of Boards of Pharmacy
Format
Computer-based adaptive selected-response examination
Exam questions
120 questions
Time limit
2.5 hours
Passing score
Pass or Fail
Examination outline
  • Pharmacy and Pharmacist Practice (30%)
    • Practice of pharmacy definition (eg, scope of authority, scope of practice, collaborative practice agreements and other delegative authorities, limitations or restrictions on practice)
    • Non-pharmacist personnel (eg, supervision, scope, licensure, counseling)
    • Adulterated or misbranded medications (eg, medication recalls, expiration dates, counterfeit medications, emergency use authorizations, importation, Drug Supply Chain Security Act (DSCSA))
    • Federal regulatory standards (eg, National Institute for Occupational Safety and Health (NIOSH), Occupational Safety and Health Administration (OSHA), essential copies of commercial products, patient-specific prescription requirements, anticipatory compounding)
    • United States Pharmacopeia (USP) standards on compounding and hazardous materials (eg, beyond-use dating, competency training, environmental testing, record keeping)
    • Security of patient health information
  • Medication Use Process (Prescribing, Transcribing and Documenting, Dispensing, Administering, and Monitoring) (30%)
    • Requirements for issuing prescriptions and medication orders, including controlled substances
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Validity of a prescription (eg, authority, content, corresponding responsibility)
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Changes to a prescription
    • Requirements for issuing prescriptions and medication orders, including controlled substances: Emergency prescriptions and emergency refills
    • Dispensing medications, including controlled substances
    • Dispensing medications, including controlled substances: Pharmacy and manufacturer labeling, including over-the-counter medications and patient education
    • Dispensing medications, including controlled substances: Drug utilization review
    • Dispensing medications, including controlled substances: Fills, refills, and partial fills
    • Dispensing medications, including controlled substances: Packaging and repackaging
    • Dispensing medications, including controlled substances: Counseling
    • Dispensing medications, including controlled substances: Transfers
    • Dispensing medications, including controlled substances: Prescription drug monitoring program (PDMP) requirements
    • Dispensing medications, including controlled substances: Recalls, returns, and reuse
    • Dispensing medications, including controlled substances: Drug product selection (eg, substitutions, interchangeability)
    • Administration of medications, including adverse event reporting
  • Regulatory Authority and Legal Obligations (20%)
    • Role of regulatory authorities, including authority, inspections, and discipline
    • Role of regulatory authorities, including authority, inspections, and discipline: Federal (eg, Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), US Department of Health and Human Services (HHS))
    • Role of regulatory authorities, including authority, inspections, and discipline: State (eg, board of pharmacy, department of health)
    • Controlled substances
    • Controlled substances: Inventory
    • Controlled substances: Record keeping
    • Controlled substances: Order forms and ordering
    • Controlled substances: DEA registration and power of attorney
    • Controlled substances: Theft and loss
    • Controlled substances: Disposal
    • Liability and malpractice
  • Pharmacy Operations (20%)
    • Licensures, registrations, and certifications
    • Pharmacy technology, including record keeping and automation (eg, e-prescribing, faxing, shared services)
    • Access, storage, handling, and security
Examination sources